Table 5.
Outcome | Comparison Ratio* for Hospice vs. No Hospice | |
---|---|---|
Unadjusted | Adjusted† | |
Prevalence Ratio | ||
Any Hospitalization | 0.90 (0.89–0.92) | 0.92 (0.90–0.93) |
Heart Failure Hospitalization | 0.89 (0.84–0.94) | 0.93 (0.88–0.98) |
Cardiovascular Hospitalization | 0.83 (0.80–0.87) | 0.87 (0.84–0.90) |
Non-Cardiovascular Hospitalization | 0.90 (0.88–0.92) | 0.91 (0.89–0.93) |
ICU Stay | 0.73 (0.70–0.76) | 0.78 (0.74–0.81) |
Cardiac Catheterization | 0.50 (0.42–0.60) | 0.63 (0.52–0.75) |
Implantable Cardiac Defibrillator | 0.54 (0.39–0.76) | 0.70 (0.50–0.99) |
Dialysis | 0.52 (0.46–0.59) | 0.74 (0.68–0.81) |
Cardiac Resynchronization Therapy | 0.51 (0.30–0.85) | 0.66 (0.38–1.13) |
Noninvasive Ventilation | 0.63 (0.54–0.74) | 0.67 (0.58–0.79) |
Mechanical Ventilation | 0.29 (0.26–0.32) | 0.33 (0.29–0.37) |
Incident Rate Ratio | ||
Hospitalization Rate | 0.84 (0.82–0.87) | 0.87 (0.84–0.89) |
Hospitalization Days | 0.78 (0.74–0.82) | 0.78 (0.75–0.82) |
ICU Days | 0.61 (0.56–0.66) | 0.68 (0.63–0.73) |
Cost Ratio | ||
Total Expenditures | 0.93 (0.90–0.96) | 1.04 (1.00–1.07) |
Non-Hospice Expenditures | 0.71 (0.69–0.74) | 0.77 (0.74–0.80) |
Represents prevalence ratios for bivariate outcomes, cost ratios for cost outcomes, and incident ratios for repeated outcomes
Adjusted for age, gender, race, geographic location, hospitalizations in the prior year, and comorbidities